AstraZeneca plc vs Expeditors International of Wshngtn Inc — how do they compare? AstraZeneca plc trades at $158.01 (market cap $248.14B), while Expeditors International of Wshngtn Inc trades at $177.4 (market cap $23.04B). The key difference: AstraZeneca plc is far larger — about 10.8× Expeditors International of Wshngtn Inc's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | EXPD | |
|---|---|---|
Market Cap | $248.14B | $23.04B |
Sector | Health | Industrials |
52-Week High | $209.48 | $182.80 |
52-Week Low | $147.06 | $113.13 |
Enterprise Value | $275.41B | $22.57B |
Dividend Yield | 2.01% | 0.91% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →